Recombinant Highly PathogenicAvian Influenza inactivated vaccine

Serie HPAI Vaccine

• Recombinant Avian Influenza inactivated vaccine (H5N1 subtype Strain Re-5)
• Recombinant Avian Influenza inactivated vaccine (H5N1 subtype Strain Re-6)
• Recombinant Avian Influenza（H5 Subtype） inactivated vaccine （Strain Re-6+ Strain Re-8)
• Recombinant Avian Influenza inactivated vaccine (H5N6 subtype Strain Re-13+ H5N8 subtype Strain Re-14)
• Recombinant Avian Influenza（H5 Subtype） inactivated vaccine （Strain Re-6+ Strain Re-7+ Strain Re-8)
• Recombinant Avian Influenza inactivated vaccine (H5N1 subtype Strain Re-11+ Strain Re-12，H7N9 subtype Strain H7-Re3))
• Recombinant Avian Influenza inactivated vaccine (H5N6 subtype Strain Re-13+ H5N6 subtype Strain Re-14+H7N9 subtype Strain H7-Re4)

Posology and method of administration

• Subcutaneous (at the site of neck) or intramuscular (at the site of breast) route
• Chicken: 2 to 5 weeks old, 0.3ml/bird; older than 5 weeks, 0.3ml/bird
• Duck: 2 to 5 weeks old, 0.5ml/bird; older than 5 weeks, 1ml/bird
• Goose: 2 to 5 weeks old, 0.5ml/bird; older than 5 weeks, 1.5ml/bird

Shelf-life ：12 months (ND: data available to show stability over 24 months)

Comprehensive Customized Development Strain Solution

• Pulike provides structure-based vaccine design services to determine the structures of antigens and helping our clients with the vaccine design.
• With years of experience, Pulike are capable to provide services for vaccine design according to customers' need. Our experts are pleased to help you with our advanced platforms and extensive experiences.